Topic resource collection
Approved comparison material connected to this topic.
4 resourcesRead both sides
BPC-157 250–500 mcg daily Upregulates VEGF-A and eNOS; promotes angiogenesis and epithelial repair 30–60 minutes before meals on empty stomach Moderate (multiple animal studies, no human RCTs) Most mechanistically robust for muco…
Clinical GERD management relies on PPIs like omeprazole and esomeprazole to reduce gastric acid secretion by 90–95%. These drugs prevent further erosion but don't actively promote tissue healing. A limitation evident in patients …
BPC-157 Angiogenesis, mucosal protection VEGFR2, FAK-paxillin signaling 14–21 days for 60–70% lesion reduction 40+ preclinical studies in gastric injury models Strongest evidence for direct tissue repair; gold standard for gastri…
| Peptide | Primary Mechanism | Tissue Target | Evidence Level | Typical Research Dose | Administration Route | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | VEGF upregulation, nitric oxide modulation | Esophageal mucosa, gas…